Why is Eiko Lifescience falling/rising?

As of 24-Sep, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at 54.01, reflecting a decrease of 0.43 or 0.79%. The stock has underperformed its sector today by 0.7%, and its delivery volume has fallen significantly by 22.14% compared to the 5-day average, indicating reduced investor participation. Over the past week, the stock has decreased by 4.31%, while it has shown a modest increase of 2.76% over the past month. Despite some positive financial results reported in June, including a substantial growth in profit before tax and operating profit margins, the stock has a weak long-term fundamental strength with an average return on equity of 2.82%, which may be contributing to the current downward price movement.
In the broader market context, Eiko Lifesciences has consistently underperformed against the benchmark, with a return of -6.36% over the past year compared to a -3.77% decline in the BSE500. This trend of underperformance has persisted over the last three years, further impacting investor sentiment. While the stock is trading at a discount relative to its peers and has shown a significant increase in profits, the overall weak long-term fundamentals and recent declines in investor participation suggest that the market remains cautious about its future performance.